Alessia Surgo

Dr. Alessia Surgo

General Regional Hospital “F. Miulli”, Acquaviva delle Fonti-Bari, Bari, Italy
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in European Urology
Verified
Journal Article
Closed access
POPiet Ost
Piet Ost
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
NANicholas Van As
Nicholas Van As
TZThomas Zilli
Thomas Zilli
AMAlexander Muacevic
Alexander Muacevic
GMGert De Meerleer
Gert De Meerleer

30 November 2017 in ecancermedicalscience
Verified
Journal Article
Open access
CGCristina Garibaldi
Cristina Garibaldi
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
GMGiulia Marvaso
Giulia Marvaso
SDSamantha Dicuonzo
Samantha Dicuonzo
DRDamaris Patricia Rojas
Damaris Patricia Rojas
RRRosalinda Ricotti
Rosalinda Ricotti
Ecancermedicalscience is the peer-reviewed open access cancer journal founded by the European Institute of Oncology in Milan. We consider articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epide

1 September 2016 in Clinical Oncology
Verified
Journal Article
Closed access
POPiet Ost
Piet Ost
BJB.A. Jereczek-Fossa
B.A. Jereczek-Fossa
NAN. Van As
N. Van As
TZT. Zilli
T. Zilli
ATA. Tree
A. Tree
GMG. De Meerleer
G. De Meerleer

1 July 2018 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Closed access
RLRoberta Lazzari
Roberta Lazzari
SRSara Ronchi
Sara Ronchi
Sara GandiniSara Gandini
Sara Gandini
Alessia SurgoAlessia Surgo
Alessia Surgo
Stefania VolpeStefania Volpe
Stefania Volpe
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa

1 September 2018 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
JKJarosław Kobiela
Jarosław Kobiela
PSPiotr Spychalski
Piotr Spychalski
GMGiulia Marvaso
Giulia Marvaso
DCD. Ciardo
D. Ciardo
VDV. Dell’aCqua
V. Dell’aCqua
BJB.A. Jereczek-Fossa
B.A. Jereczek-Fossa

9 June 2021 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
Roberta CarbonaraRoberta Carbonara
Roberta Carbonara
PBPierluigi Bonomo
Pierluigi Bonomo
ARAlessia Di Rito
Alessia Di Rito
VDVittorio Didonna
Vittorio Didonna
Fabiana GregucciFabiana Gregucci
Fabiana Gregucci
ASAngela Sardaro
Angela Sardaro
Background. Radiation-induced toxicity represents a crucial concern in oncological treatments of patients affected by head and neck neoplasms, due to its impact on survivors quality of life. Published reports suggested the potential of radiomics combined with machine learning methods in the prediction and assessment of radiation-induced toxicities, supporting a tailored radiation treatment management. In this paper, we present an update of the current knowledge concerning these modern approaches. Materials and Methods. A systematic review according to PICO-PRISMA methodology was conducted in MEDLINE/PubMed and EMBASE databases until June 2019. Studies assessing the use of radiomics combined with machine learning in predicting radiation-induced toxicity in head and neck cancer patients were specifically included. Four authors (two independently and two in concordance) assessed the methodological quality of the included studies using the Radiomic Quality Score (RQS). The overall score for each analyzed study was obtained by the sum of the single RQS items; the average and standard deviation values of the authors RQS were calculated and reported. Results. Eight included papers, presenting data on parotid glands, cochlea, masticatory muscles, and white brain matter, were specifically analyzed in this review. Only one study had an average RQS was30 (50), while 3 studies obtained a RQS almost25. Potential variability in the interpretations of specific RQS items could have influenced the inter-rater agreement in specific cases. Conclusions. Published radiomic studies provide encouraging but still limited and preliminary data that require further validation to improve the decision-making processes in preventing and managing radiation-induced toxicities.